Literature DB >> 15034787

Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.

Hui-Chuan Sun1, Zhao-You Tang.   

Abstract

Hepatocellular carcinoma (HCC) is a typical hypervascular tumor. Many angiogenic factors have been studied in HCC, and several anti-angiogenic therapies have been tested in animal models and patients. This paper summarizes the latest findings, especially regarding the clinical significance of endothelial cell markers and angiogenic factors in HCC, and experimental and clinical anti-angiogenesis therapies. Further developments in this area, such as endothelial cell-oriented research and better experimental and clinical designs in the evaluation of anti-angiogenic therapies are discussed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15034787     DOI： 10.1007/s00432-003-0530-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  136 in total

1.  Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.

Authors:  D Murphy; K M Detjen; M Welzel; B Wiedenmann; S Rosewicz
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

2.  Octreotide in hepatocellular carcinoma.

Authors:  D Shouval
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

3.  Heparin-binding angiogenesis factors: detection by immunological methods.

Authors:  M G Wadzinski; J Folkman; J Sasse; K Devey; D Ingber; M Klagsbrun
Journal:  Clin Physiol Biochem       Date:  1987

4.  Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  J Zhou; Z Y Tang; J Fan; Z Q Wu; X M Li; Y K Liu; F Liu; H C Sun; S L Ye
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

5.  Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.

Authors:  X M Li; Z Y Tang; L X Qin; J Zhou; H C Sun
Journal:  J Exp Clin Cancer Res       Date:  1999-12

6.  Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines.

Authors:  O Sedláková; J Sedlák; L Hunáková; J Jakubíková; J Duraj; M Sulíková; J Chovancová; B Chorváth
Journal:  Neoplasma       Date:  1999       Impact factor: 2.575

7.  Role of angiogenesis in hepatitis and hepatocellular carcinoma.

Authors:  C G Ker; H Y Chen; C C Juan; H W Lo; Y Y Shen; J S Chen; K T Lee; P C Sheen
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

8.  Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor.

Authors:  C Morales; M Zurita; J Vaquero
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

9.  Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.

Authors:  Martina Baur; Reinhard Walter; Axel Gebauer; Dimiter Tscholakoff; Herbert Lochs; Ferdinand Mühlbacher; Karl Turetschek; Reinhard Binder; Marcus Hudec; Alfred Gangl; Peter Ferenci; Christian Dittrich
Journal:  Int J Oncol       Date:  2003-09       Impact factor: 5.650

10.  Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin.

Authors:  Sophie De Boüard; Jean-Sébastien Guillamo; Christo Christov; Nathalie Lefévre; Pierre Brugières; Eleonora Gola; Pauline Devanz; Stefano Indraccolo; Marc Peschanski
Journal:  Hum Gene Ther       Date:  2003-06-10       Impact factor: 5.695
View more
  28 in total

1.  WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling.

Authors:  Hong Qiu; Bo Yang; Zhi-Chao Pei; Zhang Zhang; Kan Ding
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

2.  Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC).

Authors:  R A Pazo-Cid; M Lanzuela; G Esquerdo; J L Pérez-Gracia; A Antón; G Amigo; J Martínez Trufero; A L García-Otín; P Martín-Duque
Journal:  Clin Transl Oncol       Date:  2012-07-18       Impact factor: 3.405

Review 3.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.

Authors:  Seunghyun Lee; Jung Hoon Kim; Jae Hwan Lee; Jeong Hwa Lee; Joon Koo Han
Journal:  Eur Radiol       Date:  2017-07-27       Impact factor: 5.315

Review 5.  Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Authors:  Chun-Min Liang; Long Chen; Heng Hu; Hui-Ying Ma; Ling-Ling Gao; Jie Qin; Cui-Ping Zhong
Journal:  World J Hepatol       Date:  2015-06-08

6.  Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.

Authors:  Catharina M Korse; Johannes M G Bonfrer; Warner Prevoo; Paul Baas; Babs G Taal
Journal:  Tumour Biol       Date:  2011-03-05

7.  Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib.

Authors:  Camillo Porta; Chiara Paglino
Journal:  World J Hepatol       Date:  2010-03-27

8.  Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor.

Authors:  Suk Hee Heo; Yong Yeon Jeong; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Jae Hyuk Lee; Yang Seok Koh; Chol Kyoon Cho; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

9.  Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.

Authors:  Hye Jung Baek; Sung Chul Lim; Krit Kitisin; Wilma Jogunoori; Yi Tang; M Blair Marshall; Bibhuti Mishra; Tae Hyun Kim; Kwan Ho Cho; Sang Soo Kim; Lopa Mishra
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

10.  Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.

Authors:  Sumeet Virmani; Thomas K Rhee; Robert K Ryu; Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Laura M Kulik; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-10       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.